Recombinant Human Fibroblast Growth Factor-2 (rhFGF-2) In Absorbable Collagen Membrane With Coronally Advanced Flap In Class I And II Gingival Recession Defects -A Randomized Control Trial

This study was a single-arm trial to obtain preliminary data on the efficacy of collagen membranes impregnated with recombinant human fibroblast growth factor (rhFGF-2) in the treatment of Miller's class I and class II gingival recessions.

Start Date01 May 2019

Sponsor / Collaborator

SVS Institute of Dental Sciences

100 Clinical Results associated with Recombinant Human Fibroblast Growth Factor-2(SVS Institute of Dental Sciences)

100 Translational Medicine associated with Recombinant Human Fibroblast Growth Factor-2(SVS Institute of Dental Sciences)

100 Patents (Medical) associated with Recombinant Human Fibroblast Growth Factor-2(SVS Institute of Dental Sciences)

111

Literatures (Medical) associated with Recombinant Human Fibroblast Growth Factor-2(SVS Institute of Dental Sciences)

01 Aug 2024·Journal of Periodontal Research

Predictive factors of periodontal regeneration outcomes using rhFGF‐2: A case–control study

Article

Author: Nakashima, Fuminori ; Iwata, Tomoyuki ; Sasaki, Shinya ; Hamamoto, Yuta ; Ueda, Tomoya ; Kakimoto, Naoya ; Ouhara, Kazuhisa ; Yasuda, Keisuke ; Mizuno, Noriyoshi ; Mihara, Naoki ; Ninomiya, Yurika ; Matsuda, Shinji

AbstractObjectiveThis study aimed to investigate the factors influencing the clinical outcomes of regenerative therapy using recombinant human fibroblast growth factor‐2 (rhFGF‐2).BackgroundrhFGF‐2 promotes periodontal regeneration, and identifying the factors influencing this regeneration is important for optimizing the effectiveness of rhFGF‐2.Methods and MaterialsThis study used a hospital information‐integrated database to identify patients who underwent periodontal regenerative therapy with rhFGF‐2. Factors included age, smoking status, diabetes mellitus (DM), periodontal inflamed surface area (PISA) at the initial visit, whether the most posterior tooth was involved or not, and preoperative radiological bone defect angle. Periodontal regenerative therapy outcomes were defined as good if radiographic bone fill ≥35% or periodontal pocket closure at 9–15 months after surgery. Bone fill rate (%) and periodontal pocket depth (mm) were also used as outcome measures. Factors were evaluated by simple regression analysis, and then the association between factors and the outcomes was determined by multivariate analysis.ResultsPISA and age at the first visit did not significantly influence the success or failure of bone fill rate byrhFGF‐2. However, DM, radiographic bone defect angle, and the most posterior tooth significantly influenced the regenerative effect (success/failure in bone fill) of rhFGF‐2. The most posterior tooth was significantly associated with bone fill rate by rhFGF‐2. Examination of the association between pocket closure and factors shows that the most posterior tooth significantly influenced. The most posterior tooth and preoperative PPD were significantly associated with pocket reduction depth. For the most posterior tooth, a significantly higher bone regeneration rate (p < .05) was observed with a combination of autologous bone graft and rhFGF‐2 than with rhFGF‐2 alone, and the effect was significant in multivariate analysis.ConclusionsThe radiographic bone defect angle, the involvement of most posterior teeth, and the presence of DM influenced the effectiveness of rhFGF‐2 in periodontal regeneration. However, PISA values and age at the initial visit had no significant effect.

01 Jun 2024·Clinical Advances in Periodontics

Double‐sided entire papilla preservation technique in the combination periodontal regenerative therapy: A case report

Article

Author: Ishikawa, Tomohiro ; Yoshikawa, Kouki ; Ogawa, Yudai ; Imamura, Kentaro ; Saito, Atsushi

AbstractBackgroundWith the entire papilla preservation (EPP) technique, it is possible to perform regenerative therapy without incisions in the interdental papilla and to reduce the risk of papillary rupture. However, one limitation of the EPP is the sole access from the buccal side. Here, we present a case of periodontitis treated by the combination regenerative therapy employing the Double‐sided (buccal‐palatal) EPP (DEPP) technique, which adds a palatal vertical incision to the EPP.MethodsA patient with 1–2 wall intrabony defects received the regenerative therapy using recombinant human fibroblast growth factor (rhFGF)‐2 and carbonate apatite (CO3Ap). Using the DEPP technique, vertical incisions at buccal and palatal aspects were placed to gain adequate access to the 1–2 wall intrabony defects between #11 and #12 without incision in the interdental papilla. After debridement, rhFGF‐2 and CO3Ap were applied to the defect. Periodontal clinical parameters and radiographic images were evaluated at the first visit, following initial periodontal therapy (baseline), 6, 9, and 12 months postoperatively.ResultsWound healing was uneventful. Scarring of the incision lines was minimal. At 12 months postoperatively, probing depth reduction was 4 mm, clinical attachment gain was 4 mm, and gingival recession was not observed. An improvement in radiopacity in the previous bone defect was observed.ConclusionThe DEPP is an innovative technique that allows approaching from both the buccal and palatal sides while ensuring flap extensibility without compromising the interdental papilla. This report suggests that the combination of regenerative therapy with the DEPP may be promising in the treatment of intrabony defects.Key pointsWhy is this case new information?

The DEPP allows a direct visual approach to a 1–2 wall intrabony defect extending from the buccal to palatal sides, and increases flap extensibility, without compromising the papilla.

What are the keys to the successful management of this case?

Assessment of three‐dimensional bone defect morphology is required. Computed tomography images are very useful. The flap elevation just under the interdental papilla should be carefully performed with a small excavator to avoid damage to the interdental papilla.

What are the primary limitations to success in this case?

Despite the addition of a palatal incision, it was not possible to obtain complete flexibility of the palatal gingiva. Caution must be taken in a case in which the distance between the interdental papilla is narrow. Even if the interdental papilla is ruptured during the operation, recovery is possible by continuing the operation and suturing the rupture at the end.

10 Jan 2024·International Journal of Periodontics & Restorative Dentistry

Entire Papilla Preservation Technique with Recombinant Human Fibroblast Growth Factor-2 and Autogenous Bone Grafting in the Treatment of Isolated Non-Contained Intrabony Defect: Case Report of a 5-Year Follow-Up

Article

Author: Ogawa, Yudai ; Aslan, Serhat ; Nara, Yoshitaka

Regenerative periodontal surgery is an effective procedure for the treatment of intrabony defects. Various flap designs preserving the defect-associated interdental papilla have been proposed to improve early wound stability. This case report describes the long-term results of a regenerative treatment in severely compromised mandibular canine using entire papilla preservation technique. Surgical access was provided by a single buccal vertical incision without any papilla incision. Combination of autogenous bone harvested from the same surgical site and recombinant human fibroblast growth factor-2 was applied to non-contained intrabony defect following the granulation tissue removal. Surgical site was closed with single interrupted sutures. The clinical outcomes and 5-year stability of pocket closure with no increase in gingival recession show the potential of entire papilla preservation technique with the use of combined biomaterials.

100 Deals associated with Recombinant Human Fibroblast Growth Factor-2(SVS Institute of Dental Sciences)

R&D Status

10 top R&D records.

to view more data

Indication	Highest Phase	Country/Location	Organization	Date
Acquired Immunodeficiency Syndrome	Phase 2	-	Universidade Federal Fluminense	31 Dec 2002
Aggressive Periodontitis	Phase 2	-	Universidade Federal Fluminense	31 Dec 2002
Behcet Syndrome	Phase 2	-	Universidade Federal Fluminense	31 Dec 2002
Bone defects	Phase 2	-	Universidade Federal Fluminense	31 Dec 2002
Chronic Periodontitis	Phase 2	-	Universidade Federal Fluminense	31 Dec 2002
Diabetes Mellitus, Type 2	Phase 2	-	Universidade Federal Fluminense	31 Dec 2002
Gingival Recession	Phase 2	-	Universidade Federal Fluminense	31 Dec 2002
Oral Hemorrhage	Phase 2	-	Universidade Federal Fluminense	31 Dec 2002
Sepsis	Phase 2	-	Universidade Federal Fluminense	31 Dec 2002

Clinical Result

Indication

Phase

Evaluation

View All Results

Translational Medicine

Boost your research with our translational medicine data.

view full example data

Deal

Boost your decision using our deal data.

view full example data

Core Patent

Boost your research with our Core Patent data.

view full example data

Clinical Trial

Identify the latest clinical trials across global registries.

view full example data

Approval

Accelerate your research with the latest regulatory approval information.

view full example data

Regulation

Understand key drug designations in just a few clicks with Synapse.

view full example data

Chat with Hiro

Get started for free today!

Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.

Start your data trial now!

Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.

Bio

Bio Sequences Search & Analysis

Chemical

Chemical Structures Search & Analysis


No Data

Recombinant Human Fibroblast Growth Factor-2(SVS Institute of Dental Sciences)

Overview

Basic Info

Related

R&D Status

Clinical Result

Translational Medicine

Deal

Core Patent

Clinical Trial

Approval

Regulation